Forehead Filler: Why a Flat or Sloping Forehead Is Now an Injection Request, Why the Forehead Is One of the Most Dangerous Places to Inject, and Why Filler Is the Wrong Answer for Most Forehead Lines

For most of the history of injectables, nobody asked to have their forehead filled. The forehead was where neurotoxin went, and the conversation was about lines, not shape. That has changed. Social media profiles photographed in three-quarter view, the influence of East Asian aesthetic practice where a rounded, convex forehead has long been a common request, and the general drift of filler into every region of the face have produced a new consultation: a patient who thinks their forehead is too flat, too sloped, too dented along the sides, or too hollow above the brows, and who has been told that a syringe or two will round it out in half an hour.

Forehead filler can do that, in the right hands and the right patient. It is also one of the riskiest places in the face to put a needle, it is not an FDA-approved indication for any hyaluronic acid filler we are aware of, and it is frequently offered for a problem it does not solve: the horizontal lines across the forehead, which are the visible work of a muscle holding the eyebrows up. This piece takes those three facts in order. It sits alongside the piece on filler for hollow temples, which covers the region directly beside the forehead, and the piece on filler vascular occlusion, which covers the complication that makes this region different.

What forehead augmentation is for: flat, sloping, and hollowed foreheads

The short answer: forehead filler is used to add convexity to a forehead that is flat, sloping, or concave, to smooth the dents that form along the temporal fusion lines and above the brows with age, and to soften the transition between the forehead and a hollow temple, and it is a shape procedure, not a line procedure.

Foreheads vary more than most people notice. In profile, some slope backward from the brow at a steep angle, some rise nearly vertically, and some bow gently forward. Seen from the front, a forehead can be smoothly rounded or can show a central flat plane with shallow valleys on either side, along the ridges where the temporal muscle attaches to the skull. Aging adds to this. The fat under the forehead skin thins, the bone remodels slowly, and the skin itself loses thickness, a process described in the piece on skin thinning with age. The result can be a forehead that shows the contour of the skull more clearly, with a shelf above the brows and grooves at the sides.

The requests that come to injectors fall into a few groups. The first is purely aesthetic reshaping: a patient who wants a rounder, more convex forehead in profile, often a younger patient and often influenced by an aesthetic in which a full forehead reads as youthful and feminine. The second is age-related hollowing, usually in patients over forty, where the goal is to restore a curve that used to be there. The third is contour irregularity: a dent from an old injury, a depression left after removal of a lipoma or cyst of the kind described in the piece on cyst and lipoma removal, or an uneven surface after previous surgery. The fourth is transition work, where filler is placed to blend a hollow temple into the forehead so the side of the upper face does not look pinched.

These are legitimate goals, and in the first two groups the sensible consultation starts with a question about proportion rather than product. A forehead that is rounded without regard to the brow, the nose, and the hairline can make the upper third of the face look heavy, and it can shift the apparent position of the brows. It is worth knowing that one of the most common forehead operations in plastic surgery runs in exactly the opposite direction: facial feminization surgery often reduces a prominent brow ridge and flattens a projecting forehead. The shape one patient wants added is the shape another patient pays to have removed, which is a reminder that the goal is a relationship between features, not a single ideal.

The patient who asks for forehead filler because they dislike their horizontal lines is in a different category altogether, and the fourth section of this piece is about them.

Why the forehead is one of the most dangerous places to inject

The short answer: the arteries of the forehead (the supratrochlear, the supraorbital, and branches of the superficial temporal) connect to the ophthalmic artery that supplies the eye, so filler injected into one of them can travel backward and block the retinal circulation, and in the published case reviews of filler-related blindness the forehead sits alongside the glabella, the nose, and the nasolabial fold among the leading sites.

The anatomy is the whole story. The supratrochlear and supraorbital arteries leave the orbit near the inner and central part of the eyebrow, climb over the rim of the eye socket, and run upward across the forehead. They are branches of the ophthalmic artery, which is itself the first branch of the internal carotid artery and the source of the central retinal artery. Across the forehead and temple they connect with branches of the superficial temporal artery, which comes from the external carotid system. That web of connections is normally harmless. When filler is injected into one of these vessels under pressure, it can push backward against the direction of blood flow, reach the ophthalmic artery, and then be carried forward into the arteries of the eye. The retina tolerates interrupted blood flow for a very short time.

A review of published cases by Beleznay and colleagues in Dermatologic Surgery in 2015, and an update by the same group in 2019, collected the reported cases of visual loss after filler worldwide. The regions most often involved were the glabella (the area between the brows), the nose, the nasolabial fold, and the forehead. Visual loss in these reports was usually sudden and painful, sometimes with drooping of the eyelid, loss of eye movement, or skin changes across the forehead, and in most cases vision did not fully recover despite treatment. Some cases also involved stroke, because the same backward route can reach the brain. The U.S. Food and Drug Administration issued a safety communication in 2015 warning of unintentional injection of soft tissue filler into blood vessels in the face and listing the forehead among the areas of concern. The fuller discussion of how often this happens, and what an injector should be prepared to do about it, is in the earlier piece on vascular occlusion linked above.

"A forehead does not look dangerous. It is broad, flat, and bony, and that is exactly why people underestimate it. The arteries that cross it lead back to the eye."

Blindness is the catastrophic end of the spectrum and is rare. The more common vascular problem is an occlusion that affects the skin: blanching, then a mottled, dusky pattern across part of the forehead, which, if untreated, can progress to skin death and scarring. Forehead skin has a generous blood supply in most people, which helps, but the principle is the same as anywhere in the face. Hyaluronic acid filler can be broken down with hyaluronidase, which is why an injector working in this region should have it in the room, as the piece on dissolving dermal filler explains. Hyaluronidase is far less reliable once filler has reached the retinal circulation, and fat, the other substance injected into foreheads, cannot be dissolved at all.

None of this means forehead filler cannot be done safely. It means the margin for error is narrower than in the cheek or the jawline, and that the product, the plane, and the person holding the syringe all matter more.

The safe plane, the product, and the cannula question

The short answer: experienced injectors place forehead filler deep, in the loose layer beneath the frontalis muscle and its fascia just above the bone, away from the brow where the arteries emerge, in small amounts, with slow low-pressure injection, most often with a blunt cannula, and they choose a hyaluronic acid product that spreads smoothly rather than a stiff or permanent one.

The arteries of the forehead do not sit at one depth. Near the eyebrow they run deep, close to the bone, as they leave the orbit. A short distance above the brow they turn and travel upward in more superficial layers, within and above the frontalis muscle. That pattern has shaped the technique most published by facial anatomists: stay well above the danger zone just over the brow, and place product in the deep, relatively bloodless layer under the muscle and its fascia (often called the subgaleal or loose areolar plane) where the main vessels are not running. In that layer, a modest volume spreads into a smooth curve rather than sitting as a visible lump, which is also why deep placement looks better as well as being safer.

The cannula question is not settled but is lopsided. A blunt-tipped cannula is less likely to pierce an artery than a sharp needle, and many injectors who do forehead work use one for that reason, entering through one or two small openings and fanning product across the plane. A cannula is not a guarantee: it can enter a vessel, particularly a narrow one, and a small-gauge cannula behaves more like a needle than a large one. Aspirating before injection, pulling back on the plunger to look for blood, is widely taught and widely criticized as unreliable with thick fillers and fine needles. The consistent recommendations across the safety literature are the ones that do not depend on luck: small aliquots, slow injection at low pressure, constant movement, and constant attention to the skin for blanching.

Product choice matters. The forehead has thin skin over bone, and a stiff, highly cross-linked filler placed there can be felt and seen as ridges. A softer hyaluronic acid that integrates smoothly is the usual choice, and it has the advantage of being reversible. Forehead contouring is an off-label use: none of the hyaluronic acid fillers approved in the United States that we are aware of carries a forehead augmentation indication, which means the product has not been studied for this site in a formal trial submitted to the FDA. Off-label use is legal and common in medicine, but it is the patient's right to be told. The approved and unapproved categories of injectable are discussed in the piece on skin boosters and what is approved.

Two groups of products deserve particular skepticism on the forehead. Biostimulators such as poly-L-lactic acid are sometimes used to thicken the forehead gradually, and they do have a place in experienced hands, but they cannot be dissolved and they carry a risk of nodules that are visible in thin skin, as the piece on biostimulatory fillers versus hyaluronic acid and the piece on delayed filler nodules describe. Permanent fillers and anything that sounds like silicone oil have no place there at all, for reasons laid out in the piece on illegal silicone injections.

Why filler is the wrong answer for most forehead lines

The short answer: horizontal forehead lines are creases made by the frontalis, the only muscle that lifts the eyebrows, and in many adults that muscle is working constantly to hold heavy brows or lids out of the line of sight; neurotoxin, not filler, is the treatment for the movement, filler placed superficially into lines in thin forehead skin tends to look lumpy or bluish, and lines that are a sign of brow or eyelid drooping belong to a surgical conversation.

Many forehead filler consultations begin with lines, not shape. A patient has had neurotoxin, the lines have softened but not vanished, and someone suggests filling what is left. It is worth understanding what those lines are. The frontalis lifts the eyebrows every time we look up, express surprise, or try to open the eyes wider. Its repeated contraction folds the skin above it into horizontal creases. Over time, and with thinning skin, some of those creases remain visible even when the muscle is relaxed, which is the difference between dynamic and static lines described in the piece on preventative Botox.

The first issue is that the frontalis is often doing necessary work. When the eyebrows sit low, or when the upper eyelid skin is heavy, or when the eyelid itself droops because the muscle that lifts it has stretched, people compensate without knowing it by raising their brows all day. Their forehead lines are the record of that effort. Relax the frontalis with too much neurotoxin and the brows drop, the eyelids feel heavy, and the patient looks tired or angry. That trade-off is the core of the piece on hooded eyes versus brow ptosis and the piece on eyelid ptosis versus blepharoplasty. A patient in that situation whose lines are then filled has had the symptom treated while the cause, a brow or lid that needs lifting, goes unaddressed. The surgical options are set out in the piece on lateral brow lift versus forehead lift, and the more limited neurotoxin approach to raising the brow is covered in the piece on the chemical brow lift.

The second issue is the tissue. Treating a fine line with filler means placing product close to the surface, and forehead skin over bone is thin and unforgiving. Hyaluronic acid placed too superficially can show as a raised ridge along the line, or as a faint bluish tinge from the way light scatters through it, known as the Tyndall effect. Superficial placement also puts the product in the layer where the arteries run after they leave the brow. Some injectors use very diluted hyaluronic acid or skin-quality products in tiny amounts for etched lines, and that can help in carefully chosen cases, but it is a refinement after the muscle has been addressed, not a replacement for addressing it. Combining the two in one visit is common, and the piece on Botox and filler in one visit covers the order and the reasoning.

The third issue is that static lines are a skin problem as much as a volume problem. Resurfacing, which thickens the dermis and smooths its surface, often does more for etched forehead lines than any injection, with the trade-offs discussed in the piece on ablative versus non-ablative laser resurfacing.

Fat, implants, and who should be doing this

The short answer: fat grafting can round a forehead with living tissue but carries a higher risk of a catastrophic embolic event because fat cannot be dissolved, custom or preformed implants and bone cement offer a permanent surgical route for larger contour changes, and forehead filler belongs with an injector who works in the forehead regularly, knows its vascular anatomy, and can recognize and treat an occlusion on the spot.

Fat transfer is the other common way to add volume to the forehead, and in some East Asian practices it has been a staple for years. It has real advantages: the patient's own tissue, a potentially long-lasting result, and a soft, natural feel. The general principles and the limits of fat survival are set out in the piece on fat transfer to the face and the piece on fat graft survival. The forehead version carries two particular problems. Survival is unpredictable, so results can be uneven and may need a second session. And the embolic risk is worse: fat particles are larger than filler droplets, cannot be broken down with an enzyme, and many of the most severe reported cases of blindness and stroke after facial injection involved fat into the forehead and glabella. Fat can also become lumpy or form cysts in thin skin, as the piece on fat necrosis after fat transfer describes.

For patients who want a larger or permanent change, such as a very flat or concave forehead, a post-traumatic defect, or a contour irregularity after previous surgery, the surgical options are implants and bone cements. Silicone or porous polyethylene implants can be placed on the bone, often through an endoscopic approach or a coronal incision behind the hairline, and custom implants designed from a CT scan, sometimes in PEEK or similar materials, are used for more complex reshaping. Hydroxyapatite and other bone cements can be shaped onto the skull in reconstructive practice. These operations carry the familiar implant risks of infection, displacement, and a visible edge in thin skin, discussed in the piece on cheek and jaw implants. When the concern is the height of the forehead rather than its curve, the relevant operation is hairline lowering, not augmentation.

On who should inject: a surgeon's board certification, a nurse injector's licensure, and a med spa's supervising physician are all worth checking, for reasons laid out in the piece on med spa supervision. The more useful questions are specific to this region. How many forehead contour treatments has the injector done in the last year, which plane do they use, do they use a cannula, and what is their written protocol for an occlusion, including who they call if a patient reports a change in vision? A practice that has a protocol will be glad you asked. A practice that has not thought about it will tell you the forehead is one of the easiest areas to treat.

There are also quieter failures to watch for. Filler placed too high or in too large a volume can make the forehead look swollen and shiny, a look that reads as done rather than restored, which is the problem the piece on how to avoid looking fake is about. Filler can migrate downward over months, collecting above the brows or even in the upper eyelids, as the piece on filler migration describes. And because hyaluronic acid in the forehead can persist longer than product in more mobile areas, the costs of repeated top-ups, discussed in the piece on how long results last, can quietly accumulate into a heavier forehead than the patient ever asked for.

The honest summary

Forehead filler is a shape procedure. In a patient with a genuinely flat, sloping, or age-hollowed forehead, a skilled injector can add a subtle convexity with hyaluronic acid placed deep beneath the frontalis, above the danger zone over the brows, in small amounts with slow low-pressure injection, usually with a cannula, and with hyaluronidase in the room. Done that way it can soften the transition to the temples and restore a curve that aging has flattened. It is also an off-label use in the United States, and the forehead sits among the glabella, the nose, and the nasolabial fold as a leading site in published reports of filler-related blindness, because the supratrochlear and supraorbital arteries crossing it lead back to the ophthalmic artery and the retina. Fat carries a higher embolic risk than hyaluronic acid because it cannot be dissolved, and biostimulators and permanent fillers are poor choices in thin forehead skin. Filler is usually the wrong answer for horizontal forehead lines, which are made by a muscle that often holds heavy brows or lids up; the right answers there are neurotoxin used with restraint, resurfacing for etched lines, and an examination of the brows and eyelids before anyone fills anything. Larger or permanent contour changes belong to implants and surgery, not to syringes. The patient this treatment serves well knows whether they are unhappy with the shape of their forehead or the lines on it, has had their brows and lids examined, and has chosen an injector who can explain the forehead's arteries before touching them.